2018
DOI: 10.1002/jbm.b.34158
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of resorbable polydioxanone and polyglycolic acid meshes in a rat model of ventral hernia repair

Abstract: The objective of this study was to evaluate physical, mechanical, and biological properties of the polydioxanone (PDO) monofilament meshes and polyglycolide (PGA) polyfilament meshes in comparison with Permacol implants. In rat experimental model, a 1.5 × 2.0 cm defect in abdominal wall was reconstructed by using the Permacol surgical implant or knitted meshes produced from either PDO monofilament, or PGA multifilament. The implant sites were assessed for the tensile strength and the extents of material resorp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
7
0
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 24 publications
(30 reference statements)
1
7
0
1
Order By: Relevance
“…The mesh is a monofilamentous construct and the constituent PDO offers intermediate in vivo durability of approximately 6 to 8 months in contrast to polyglactin 910 (2-4 months) and P4HB (18-24 months), combined with superior biocompatibility. 17 This is in line with preclinical data demonstrating evidence of mesh incorporation at 1 month and resolution of ongoing foreign body reaction by the 12-month mark. 18-20 The mid-range bioabsorption timeframe of PDO aims to strike the balance of providing mechanical support until the natural wound healing process is able to replace the mesh prosthesis with a stable capsule while avoiding long-term surgical site complications.…”
Section: Discussionsupporting
confidence: 82%
“…The mesh is a monofilamentous construct and the constituent PDO offers intermediate in vivo durability of approximately 6 to 8 months in contrast to polyglactin 910 (2-4 months) and P4HB (18-24 months), combined with superior biocompatibility. 17 This is in line with preclinical data demonstrating evidence of mesh incorporation at 1 month and resolution of ongoing foreign body reaction by the 12-month mark. 18-20 The mid-range bioabsorption timeframe of PDO aims to strike the balance of providing mechanical support until the natural wound healing process is able to replace the mesh prosthesis with a stable capsule while avoiding long-term surgical site complications.…”
Section: Discussionsupporting
confidence: 82%
“…An ideal synthetic resorbable material must exhibit high porosity to promote tissue ingrowth and reduce the risk of tissue defect recurrence [ 42 ]. Therefore, the structural morphology and superficial topography of the PDO membrane examined in this study are similar to those of the ECM ( Figure 1 ), in which the physicochemical and morphological properties facilitate the diffusion of biological fluids and cell adhesion [ 4 ].…”
Section: Discussionmentioning
confidence: 99%
“…These devices are made of one or more degradable materials which biodeteriorate in the short-term (days-weeks), mid-term (weeks-months) or long-term (months-years). Resorbable meshes are mainly composed of poly-4-hydroxybutyrate (P4HB) [40], polyglactin (PGL) [41], polylactic acid (PLA) [42], polyglycolic acid (PGA) [43], trimethylene carbonate (TMC) [44], polycaprolactone (PCL) [45], polyvinyl alcohol (PVA) [46], and combinations of these.…”
Section: Current Trends For Synthetic Meshesmentioning
confidence: 99%